Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 19489 [2013-07442]

Download as PDF Federal Register / Vol. 78, No. 62 / Monday, April 1, 2013 / Notices 19489 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review pmangrum on DSK3VPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Evaluating the Feasibility of a National Surveillance System for Breast, Cervical and Colorectal Cancer Screening, Special Interest Projects (SIP)13–065; and Using Small Media to Increase Breast and Cervical Cancer Population—Based Prevention Activities SIP13–066, Panel A, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–6:00 p.m., May 7, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Evaluating the Feasibility of a National Surveillance System for Breast, Cervical and Colorectal Cancer Screening, SIP13–065; and Using Small Media to Increase Breast and Cervical Cancer Population—Based Prevention Activities SIP13–066, Panel A,’’ initial review.’’ Contact Person For More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–46, Atlanta, Georgia 30341, Telephone: (770) 488– 3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–46, Atlanta, Georgia 30341, Telephone: (770) 488– 3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. The meeting announced below concerns Understanding the Barriers to Colorectal Cancer Screening among Asian Subgroups, Special Interest Project (SIP)13–067; and Feasibility Study of the New Clinical Measure of Colorectal Cancer Screening for Federally Qualified Health Centers (FQHCs), SIP13–069, Panel B, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–6:00 p.m., May 8, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Understanding the Barriers to Colorectal Cancer Screening among Asian Subgroups, SIP13–067; and Feasibility Study of the New Clinical Measure of Colorectal Cancer Screening for Federally Qualified Health Centers (FQHCs), SIP13–069, Panel B, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–46, Atlanta, Georgia 30341, Telephone: (770) 488– 3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Dana Redford, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. 2013–07440 Filed 3–29–13; 8:45 am] [FR Doc. 2013–07442 Filed 3–29–13; 8:45 am] [FR Doc. 2013–07441 Filed 3–29–13; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P BILLING CODE 4163–18–P VerDate Mar<15>2010 15:34 Mar 29, 2013 Jkt 229001 The meeting announced below concerns Low Dose CT Lung Cancer Screening: Informed Decision Making and Smoking Cessation, Special Interest Project (SIP)13–068; and Tobacco Use Quitline Registries for Continuously Engaging Participants in Cessation, SIP13–073, Panel C, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–6:00 p.m., May 9, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Low Dose CT Lung Cancer Screening: Informed Decision Making and Smoking Cessation, SIP13–068; and Tobacco Use Quitline Registries for Continuously Engaging Participants in Cessation, SIP13–073, Panel C, initial review.’’ CONTACT PERSON FOR MORE INFORMATION: PO 00000 Frm 00046 Fmt 4703 Sfmt 9990 E:\FR\FM\01APN1.SGM 01APN1

Agencies

[Federal Register Volume 78, Number 62 (Monday, April 1, 2013)]
[Notices]
[Page 19489]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07442]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Low Dose CT Lung Cancer 
Screening: Informed Decision Making and Smoking Cessation, Special 
Interest Project (SIP)13-068; and Tobacco Use Quitline Registries for 
Continuously Engaging Participants in Cessation, SIP13-073, Panel C, 
initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date: 11:00 a.m.-6:00 p.m., May 9, 2013 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of ``Low Dose CT Lung Cancer 
Screening: Informed Decision Making and Smoking Cessation, SIP13-068; 
and Tobacco Use Quitline Registries for Continuously Engaging 
Participants in Cessation, SIP13-073, Panel C, initial review.''

Contact Person For More Information: M. Chris Langub, Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-46, Atlanta, 
Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-07442 Filed 3-29-13; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.